Congenital hyperinsulinism

Gene: HK1

Green List (high evidence)

HK1 (hexokinase 1)
EnsemblGeneIds (GRCh38): ENSG00000156515
EnsemblGeneIds (GRCh37): ENSG00000156515
OMIM: 142600, Gene2Phenotype
HK1 is in 10 panels

3 reviews

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green and the mode of inheritance set to 'MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown' following NHS Genomic Medicine Service approval.
Created: 31 Jan 2023, 4:38 p.m. | Last Modified: 31 Jan 2023, 4:38 p.m.
Panel Version: 2.32

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Fourteen non-coding de novo mutations affecting a 42bp conserved region, encompassed by a regulatory element in intron 2 of HK1 have been associated with congenital hyperinsulinism (Wakeling et al Nature Genetics 2022 (accepted for publication) medRxiv preprint doi: https://doi.org/10.1101/2021.12.03.21267240).
Created: 27 Sep 2022, 3:03 p.m. | Last Modified: 27 Sep 2022, 3:20 p.m.
Panel Version: 2.26
Comment on publications: this article is a preprint, the PMID will be added when available
Created: 27 Sep 2022, 1:57 p.m. | Last Modified: 27 Sep 2022, 3:22 p.m.
Panel Version: 2.26

Eleanor Williams (Genomics England Curator)

Comment on list classification: Recommended for GREEN rating following GMS review. Sufficient cases. The paper has not yet been published but has been accepted for publication. Note that the variants are in a non-coding region and therefore may not be prioritised by tiering in the current Genomics England pipeline.
Created: 11 Oct 2022, 12:22 p.m. | Last Modified: 11 Oct 2022, 12:22 p.m.
Panel Version: 2.30
Review on behalf of Jayne Houghton and Kevin Colclough, Exeter Genomics Laboratory, SWGLH. Wakeling et al Nature Genetics 2022 (accepted for publication) medRxiv preprint doi: https://doi.org/10.1101/2021.12.03.21267240; HK1 non-coding pathogenic variants cause a beta-cell specific defect with no common additional features between patients. Medical management is often ineffective leading to pancreatic resection. Whilst bi-allelic loss-of-function HK1 variants cause non-spherocytic haemolytic anaemia, dominant or recessive coding variants have not been described in individuals with defects in glucose homeostasis. Variants in this region have revealed a new disease mechanism for non-coding variants that cause inappropriate expression of a disallowed gene. To date 14 probands with isolated hyperinsulinism have been identified in which 9 different de novo variants have been identified. In resected pancreatic tissue of individuals with non-coding variants within this regulatory region, HK1 was expressed and co-localised with insulin in the islets of affected tissue but not in unaffected controls. HK1 did not co-localise with glucagon (secreted by pancreatic alpha-cells) supporting the impact of the variants being beta-cell specific and confirming that the variants cause HK1 to be inappropriately expressed in the pancreatic beta cell and explain why there is increased insulin secretion in these individuals during hypoglycaemia.
Created: 14 Sep 2022, 4:39 p.m. | Last Modified: 14 Sep 2022, 4:39 p.m.
Panel Version: 2.12

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Congenital hyperinsulinism

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • NHS GMS
  • Expert Review Green
  • Expert review
Phenotypes
  • Congenital hyperinsulinism
Tags
non-coding-known-pathogenic
OMIM
142600
Clinvar variants
Variants in HK1
Penetrance
None
Publications
  • https://doi.org/10.1101/2021.12.03.21267240
Panels with this gene

History Filter Activity

31 Jan 2023, Gel status: 3

Removed Tag, Removed Tag, Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_22_rating was removed from gene: HK1. Tag Q3_22_MOI was removed from gene: HK1. Tag Q3_22_NHS_review was removed from gene: HK1.

31 Jan 2023, Gel status: 3

Added New Source, Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source Expert Review Green was added to HK1. Source NHS GMS was added to HK1. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

11 Oct 2022, Gel status: 2

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: hk1 has been classified as Amber List (Moderate Evidence).

27 Sep 2022, Gel status: 2

Added Tag, Added Tag, Added Tag, Added Tag

Sarah Leigh (Genomics England Curator)

Tag non-coding-known-pathogenic tag was added to gene: HK1. Tag Q3_22_rating tag was added to gene: HK1. Tag Q3_22_MOI tag was added to gene: HK1. Tag Q3_22_NHS_review tag was added to gene: HK1.

27 Sep 2022, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: hk1 has been classified as Amber List (Moderate Evidence).

27 Sep 2022, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: HK1 were changed from to Congenital hyperinsulinism

27 Sep 2022, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: HK1 were set to

23 Sep 2022, Gel status: 1

Set mode of inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for gene: HK1 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

14 Sep 2022, Gel status: 1

Created, Added New Source, Set mode of inheritance

Eleanor Williams (Genomics England Curator)

gene: HK1 was added gene: HK1 was added to Congenital hyperinsulinism. Sources: Expert review Mode of inheritance for gene: HK1 was set to